Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of tumor-associated antigens in breast cancer subtypes.
Curigliano G, Bagnardi V, Ghioni M, Louahed J, Brichard V, Lehmann FF, Marra A, Trapani D, Criscitiello C, Viale G. Curigliano G, et al. Among authors: criscitiello c. Breast. 2020 Feb;49:202-209. doi: 10.1016/j.breast.2019.12.002. Epub 2019 Dec 12. Breast. 2020. PMID: 31869767 Free PMC article.
HER2-positive circulating tumor cells in breast cancer.
Ignatiadis M, Rothé F, Chaboteaux C, Durbecq V, Rouas G, Criscitiello C, Metallo J, Kheddoumi N, Singhal SK, Michiels S, Veys I, Rossari J, Larsimont D, Carly B, Pestrin M, Bessi S, Buxant F, Liebens F, Piccart M, Sotiriou C. Ignatiadis M, et al. Among authors: criscitiello c. PLoS One. 2011 Jan 10;6(1):e15624. doi: 10.1371/journal.pone.0015624. PLoS One. 2011. PMID: 21264346 Free PMC article.
Targeting the subtypes of breast cancer: rethinking investigational drugs.
Curigliano G, Locatelli M, Fumagalli L, Brollo J, Munzone E, Nolé F, Criscitiello C, Goldhirsch A. Curigliano G, et al. Among authors: criscitiello c. Expert Opin Investig Drugs. 2012 Feb;21(2):191-204. doi: 10.1517/13543784.2012.651456. Epub 2012 Jan 10. Expert Opin Investig Drugs. 2012. PMID: 22229343 Review.
Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.
Criscitiello C, Azim HA Jr, Agbor-tarh D, de Azambuja E, Piccart M, Baselga J, Eidtmann H, Di Cosimo S, Bradbury I, Rubio IT. Criscitiello C, et al. Ann Oncol. 2013 Aug;24(8):1980-5. doi: 10.1093/annonc/mdt129. Epub 2013 Apr 7. Ann Oncol. 2013. PMID: 23567146 Free article. Clinical Trial.
Locoregional recurrence in patients with HER2 positive breast cancer.
Brollo J, Kneubil MC, Botteri E, Rotmensz N, Duso BA, Fumagalli L, Locatelli MA, Criscitiello C, Lohsiriwat V, Goldhirsch A, Leonardi MC, Orecchia R, Curigliano G. Brollo J, et al. Among authors: criscitiello c. Breast. 2013 Oct;22(5):856-62. doi: 10.1016/j.breast.2013.03.010. Epub 2013 May 1. Breast. 2013. PMID: 23642529
Tumour dormancy and clinical implications in breast cancer.
Gelao L, Criscitiello C, Fumagalli L, Locatelli M, Manunta S, Esposito A, Minchella I, Goldhirsch A, Curigliano G. Gelao L, et al. Among authors: criscitiello c. Ecancermedicalscience. 2013 May 21;7:320. doi: 10.3332/ecancer.2013.320. Print 2013. Ecancermedicalscience. 2013. PMID: 23717341 Free PMC article.
205 results